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 2 
ABSTRACT 10 
Quality of life (QoL) plays a significant role in the treatment of dogs with idiopathic epilepsy 11 
(IE) yet is so far understudied. This study describes the outcome evaluation of an online 12 
questionnaire based on the carer’s perception focusing on 62 QoL-questions in 159 dogs with 13 
IE.  14 
Results showed that seizure frequency, but not seizure severity or presence of cluster seizures 15 
was significantly associated with carer perceived dog’s QoL. Dogs receiving third line 16 
antiepileptic drugs had a significantly lower perceived QoL than those that did not. Generalised 17 
linear mixed model analysis demonstrated that severity of the side effects sleeping more and 18 
ataxia were significantly associated with carer perceived dog’s QoL, with higher severities 19 
predicting lower QoL scores. The degree of carer acceptability of seizure frequency and severity 20 
was significantly associated with the dog’s reported seizure frequency and severity. Moreover, 21 
there was a significant association between IE-related QoL changes of the dog and the carer, 22 
with reductions in perceived canine QoL scores associated with reductions in carer QoL, and 23 
vice versa.  24 
In conclusion, aspects of canine IE can affect both the carer and their dog’s QoL. This has 25 
implications for the management and requires consideration when treatment options and 26 
outcomes are discussed. 27 
 28 
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INTRODUCTION 32 
Canine epilepsy studies mainly focus on the physical aspects of seizures, the impact of 33 
antiepileptic drugs (AED) and more recently also behavioural changes associated with the 34 
disease (Lord and Podell 1999, Chang and others 2006, Shihab and others 2011, Muñana and 35 
others 2012). The physical aspects of canine idiopathic epilepsy (IE) such as seizure frequency 36 
and severity as well as AED side effects are well described, yet the suspected impact on QoL 37 
has only been studied in small numbers of affected dogs. Carers of 37 dogs with IE were mostly 38 
concerned about the dog’s QoL, adequate seizure frequency (less than one seizure every three 39 
months) and acceptable side effects of AEDs and that these factors would determine if seizure 40 
control was adequate (Chang and others 2006).  41 
 42 
Neurobehavioral changes are a reported comorbidity of epilepsy in dogs and humans and 43 
include cognitive, behavioural or emotional changes associated with central nervous system 44 
dysfunction. These comorbidities in dogs include increased fear/anxiety, defensive aggression, 45 
abnormal perception, inattention, excitability/impulsivity, and show remarkable similarities to 46 
its human counterpart resembling anxiety and attention deficit hyperactivity disorder (Shihab 47 
and others 2011, Jokinen and others 2015, Packer and others 2016). The carer commonly 48 
assesses non-metric aspects like neurobehavioral changes and QoL aspects based on their 49 
perception (Lord and Podell 1999, Chang and others 2006, Shihab and others 2011, Muñana 50 
and others 2012, Packer and others 2016). The carer’s perception of their dog’s QoL may be 51 
biased but with this in mind the carer can serve as surrogate. This is an accepted practice not 52 
only in veterinary medicine but also in childhood epilepsy where usually the parent assesses 53 
the QoL of the epileptic child (Liu and Han 2015). It is further known that not only the QoL of 54 
the affected child but also of their carer can be affected in childhood epilepsy. Parents of 55 
epileptic children showed significantly lower QoL scores, and higher levels of depression and 56 
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anxiety correlating to seizure control, employment, financial implications of caring for an 57 
individual with epilepsy, the occurrence of status epilepticus, drug side effects and age of 58 
parents among others (Lv and others 2009). Information about the impact of caring for an 59 
epileptic dog on the carer’s QoL is limited yet effect on the carer’s day-to-day activities and 60 
their free time are describes (Lord and Podell 1999, Chang and others 2006).  61 
 62 
Wessmann et al. (2014) published the creation of a disease-specific QoL questionnaire in dogs 63 
with IE and their carers (EpiQoL). The questionnaire design was based on the multidimensional 64 
aspects of QoL as defined by the WHO into physical, social, and neurobehavioral (dog) / 65 
psychological health aspects (carer) adapted for IE (Wessmann and others 2014). The current 66 
study explores the actual data and factors that affect QoL in dogs with IE and their carers with 67 
seven hypotheses (H1-H7) utilising data from Wessmann and others (2014). The QoL measures 68 
in this study largely focused on the carer’s perception of their dog’s and their own QoL. 69 
 70 
H1: The seizure phenotype (frequency of seizure days, severity) affects the carer’s perception 71 
of QoL in canine IE patients.  72 
H2: There is an effect of being treated with certain AEDs upon carer perception of canine 73 
epilepsy.  74 
H3: Side effects of AEDs impact upon carer perception of canine QoL.  75 
H4: The reported severities of AED side effects are associated with the degree of carer 76 
acceptability of AED side effects.   77 
H5: A dog’s seizure frequency is associated with the degree of carer acceptability of seizure 78 
frequency.  79 
H6: A dog’s seizure severity is associated with the degree of carer acceptability of seizure 80 
severity.   81 
 5 
H7: There is an association between changes in carer QoL and carer perception of their dog’s 82 
QoL following the onset of IE.  83 
 84 
MATERIAL AND METHODS 85 
Carers of dogs diagnosed with IE were recruited at the authors’ institutions (UGVS, RVC) by 86 
paper mail stating a link to the online questionnaire, through contacting 800 primary care 87 
practices by email and though a canine epilepsy website (www.canineepilepsy.co.uk). Data was 88 
acquired from January to November 2011. Dogs were included if they presented with recurrent 89 
seizures (two or more) at least one month apart which were either presumptively diagnosed 90 
with IE following substantial investigation, including normal brain imaging (MRI or CT) and 91 
cerebrospinal fluid analysis independent of the age of onset or strongly suspected to have IE 92 
with seizures for more than one year and an age of onset between 6 months to 6 years. 93 
Responses were excluded if other diseases that required ongoing veterinary treatment or 94 
attention were reported or if the dog was not alive at the time of completion of the questionnaire 95 
(Wessmann and others 2014). 96 
This study reports the outcome of 36 key questions (EpiQoL) associated with IE in 159 affected 97 
dogs and their carer’s, as previously described by the authors (Supplementary file A, Wessmann 98 
and others 2014). Items such as seizure severity, frequency and side effects of AEDs were 99 
considered to affect the physical aspects of the dog. The seizure frequency considered the 100 
‘seizure days’ on which seizures occurred and therefore could include single and multiple 101 
seizures (‘cluster’) for this day. Items such as restrictions and frustrations on the carer’s life 102 
such as limitations in work, education, day-to-day activities, and social life because of caring 103 
for an epileptic dog were grouped under the social aspects affecting the carer. Psychological 104 
health aspects affecting the carer included items such as the carer’s distaste of AED side effects 105 
and carer anxiety around the seizure frequency and severity and its effects on the dog 106 
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(Supplementary file A). Twenty-six additional questionnaire items from the original project 107 
questionnaire were included such as direct QoL focused questions, descriptive data around the 108 
seizure event, psychological health aspects of the carer concerning mainly the dog’s health and 109 
the effect on the carer (Supplementary file B). A total of 62 questions were used to test the 110 
aforementioned hypotheses.  111 
 112 
Statistical analysis 113 
To investigate the above seven questions, three carer-reported proxies of canine QoL were used 114 
as outcome measures:  115 
(i) A score from 1-10 (treated as continuous, with 1 being the worst and 10 being the best);  116 
(ii) QoL in the past three months (categorical from pretty bad-very well); and  117 
(iii) Change in QoL since the onset of epilepsy (categorical from much decreased-much 118 
increased).  119 
Independent dog-related variables included aspects of the seizure phenotype: seizure frequency 120 
(seizure days), seizure severity and the occurrence of cluster seizures; AED treatment and the 121 
severity of side effects encountered. Carer-related independent variables included the degree of 122 
carer acceptability (rated from strong agreement – strong disagreement) of seizure frequency 123 
and severity, and carer reported QoL change since the onset of epilepsy (categorical from much 124 
decreased-much increased). Kruskal-Wallis and Mann-Whitney U tests were used to test for 125 
associations between outcome measure (i) and independent variables, and Chi-squared analysis 126 
for associations between outcome measures (ii) and (iii) and independent variables. Where 127 
indicated by univariate analyses (p<0.10), generalised linear mixed model (glmm) analyses 128 
were carried out, with breed taken into account as a random effect. Multicollinearity was 129 
checked for in all models, identified from inflated standard errors in the models, and thus 130 
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avoided. Model fit was assessed using the deviance and Akaike's information criterion. All tests 131 
were used two-sided with P<0.050 being considered statistically significant. 132 
 133 
RESULTS 134 
One hundred-and-fifty-nine dogs of 50 breeds met the inclusion criteria. Mean age was 5.8 135 
years (median 5.2 years, range 0.7-12.5 years), with 66 female (52 neutered) and 93 male dogs 136 
(67 neutered). The mean age of onset of seizures was 2.7 years (median 2 years, range 0.3-9.0 137 
years).  138 
 139 
The results of the 36 key questions and the additional 26 questionnaire items are displayed in 140 
Supplementary file A and B respectively. The answers to the seven carer perceived QoL 141 
questions are as follows:   142 
 143 
H1: The seizure phenotype (frequency of seizure days, severity) affects the carer’s perception 144 
of QoL in canine IE patients.  145 
Of the three measures of seizure phenotype (seizure frequency, severity and presence of cluster 146 
seizures), only one measure, seizure frequency, was significantly associated with carer 147 
perceived dog’s QoL, when scored out of ten (Kruskal-Wallis=17.5, p=0.014), when rated for 148 
the past three months categorically (X2=38.8, p=0.003), and when questioned about how it has 149 
changed since the onset of IE (X2=41.2, p=0.016). Higher seizure frequencies were associated 150 
with decreased carer perceived dog’s QoL measures, with the median QoL score for dogs 151 
experiencing less than one seizure day every six months scoring 9 (range 5-10), 41.4% of carers 152 
perceived their dog’s QoL as ‘very well: could hardly be better’ and 51.7% stating their dog’s 153 
QoL had stayed the same since the onset of epilepsy. In contrast, dogs experiencing ‘more than 154 
one seizure day every week’ had a median QoL score of 7.5 (range 4-8), with no carers reporting 155 
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their dog’s QoL ‘very well: could hardly be better’ and the majority (87.5%) stating their dog’s 156 
QoL had ‘decreased a little’ since the onset of epilepsy. There were no associations between 157 
seizure severity and the presence of cluster seizures with any measure of QoL (p>0.050). 158 
 159 
H2: There is an effect of being treated with certain AEDs upon carer perception of canine 160 
epilepsy.  161 
There was no difference in carer perceived dog’s QoL scored out of ten or in the past three 162 
months between dogs receiving phenobarbital or not, potassium bromide or not, or diazepam 163 
or not (p>0.050). When QoL was considered since the onset of epilepsy, dogs that received 164 
phenobarbital were rated by their carers to have had a reduction in QoL compared to those that 165 
did not (55.6% vs. 25.7% rated their dog’s QoL to be ‘a little decreased’ since the onset of 166 
epilepsy, respectively; p=0.008), as were dogs that received potassium bromide in comparison 167 
to those that did not (60.5% ‘a little decreased’ vs. 36.8%, respectively; p=0.017). When the 168 
number of AEDs administered was considered, there was a significant difference in carer 169 
perceived dog’s QoL between dogs being treated with third line drugs or not, when scored out 170 
of ten (Mann-Whitney= 1545, p=0.002), rated for the past 3 months categorically (X2= 10.8 171 
p=0.013), and when questioned about how it has changed since the onset of IE (X2= 13.5, 172 
p=0.009), with dogs receiving third line drugs having a reduced QoL compared to those that do 173 
not.  174 
 175 
H3: Side effects of AEDs impact upon carer perception of canine QoL (Table 1)  176 
The severity of four of the eleven reported AED side effects were significantly associated with 177 
carer perceived dog’s QoL at the univariate level: ‘drinking more’ (Kruskal-Wallis (KW): 15.5, 178 
p=0.008), ‘sleeping more’ (KW: 14.8, p=0.011), ‘wobbly/not coordinated when walking’ (KW: 179 
16.3, p=0.006) and ‘restlessness/pacing’ (KW: 21.0, p=0.001). Dogs that were not affected by 180 
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‘drinking more’ had a median carer perceived QoL score of 9.0 (range 7.0-10.0), whereas those 181 
reported to be very severely affected had a median of 8.0 (range 3.0-10.0). Dogs that were not 182 
affected by ‘sleeping more’ had a median carer perceived QoL score of 9.0 (range 5.0-10.0), 183 
whereas those reported to be very severely affected had a median of 8.0 (range 4.0-10.0). Dogs 184 
that were not affected by ‘wobbliness/not coordinated when walking’ had a median carer 185 
perceived QoL score of 9.0 (range 6.0-10.0), whereas those reported to be very severely affected 186 
had a median of 8.0 (range 5.0-10.0). Finally, dogs that were not affected by 187 
‘restlessness/pacing’ had a median carer perceived QoL score of 9.0 (range 3.0-10.0), whereas 188 
those reported to be very severely affected had a median of 8.0 (range 3.0-10.0). These four 189 
factors were tested in a generalised linear mixed model (glmm) with breed taken into account 190 
as a random effect. While four factors were significantly associated with QoL at the univariate 191 
level as stated above, only two factors remained significant when included together in a glmm 192 
showing the largest effect on QoL that was not explained by the other variables. These two 193 
factors significantly predicted carer perceived dog’s QoL: the severity of ‘sleeping more’ and 194 
the severity of being ‘wobbly/not coordinated when walking’ (p<0.050). The less severely the 195 
dog was affected by ‘sleeping more’ or being ‘wobbly/not coordinated’, the higher (better) the 196 
carer perceived dog’s QoL score. 197 
 198 
H4: The reported severities of AED side effects are associated with the degree of carer 199 
acceptability of AED side effects.  200 
The severity of seven of the eleven reported AED side effects (rated from 1-5: very mild – very 201 
severe) were significantly associated with carer reported acceptability of side effects (rated from 202 
1-5: strongly agree – strongly disagree) at the univariate level: ‘eating more’, ‘gaining weight’, 203 
‘drinking more’, ‘urinating more’, ‘sleeping more’, ‘wobbly/not coordinated when walking’ 204 
and ‘restlessness/pacing’ (p<0.050). Increased severity of these side effects was associated with 205 
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a decreased level of carer acceptability. There was no association between the severity of 206 
‘itchiness/skin rash’, ‘vomiting’, ‘diarrhoea’ and ‘coughing’ and carer-rated acceptability of 207 
side effects (p>0.050). 208 
 209 
H5: A dog’s seizure frequency is associated with the degree of carer acceptability of seizure 210 
frequency.   211 
Seizure frequency was significantly associated with the degree of carer acceptability of seizure 212 
frequency (X2=100.5, p<0.001), with carers reporting higher seizure frequencies disagreeing 213 
more that their dogs seizure frequency was acceptable and vice versa. For example, 46.4% of 214 
the carers of dogs experiencing ‘less than one seizure day every six months’ strongly agreed 215 
their dog’s seizure frequency was acceptable, whereas no carers of dogs experiencing ‘more 216 
than one seizure day every week’ strongly agreed their dog’s seizure frequency was acceptable, 217 
with 75.0% strongly disagreeing. 218 
 219 
H6: A dog’s seizure severity is associated with the degree of carer acceptability of seizure 220 
severity.  221 
Seizure severity was significantly associated with the degree of carer acceptability of seizure 222 
severity (X2=100.9, p<0.001), with carers reporting higher seizure severities disagreeing more 223 
that their dog’s seizure severity was acceptable and vice versa. For example, 37.5% of the carers 224 
of dogs experiencing ‘mild’ seizures strongly agreed their dog’s seizure severity was 225 
acceptable, whereas only 4.8% of carers of dogs experiencing ‘very severe’ seizures strongly 226 
agreed, with 61.9% strongly disagreeing that this severity was acceptable. 227 
 228 
H7: There is an association between changes in carer QoL and carer perception of their dog’s 229 
QoL following the onset of IE.   230 
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There was a significant association between the change in carer perceived dog’s QoL after the 231 
onset of IE and the change in the carer’s QoL after the onset of IE (X2=101.7, p<0.001), with 232 
carers reporting their dog’s QoL had decreased more likely to report that their QoL had 233 
decreased too, and vice versa. No carers of dogs whose perceived QoL had ‘much decreased’ 234 
after the onset of epilepsy reported their own QoL was ‘increased’ or ‘much increased’ (0.0%), 235 
with 50.0% stating their QoL was also ‘much decreased’. Participants commented on suffering 236 
to some degree from depression or panic attacks (29.0%) and feeling isolated (22.0%) as a result 237 
of caring for an epileptic dog (Supplementary file B). In contrast, the majority (71.4%) of carers 238 
who perceived their dog’s QoL was ‘much increased’ after the onset of epilepsy reported their 239 
own QoL was also ‘much increased’. 240 
 241 
DISCUSSION 242 
Of the three measures of seizure phenotype (seizure frequency, severity and presence of cluster 243 
seizures), only one measure, seizure frequency (seizure days), was significantly associated with 244 
QoL as perceived by the dog’s carer in this study. Chang and others (2006) reported that carers 245 
of 29 dogs referred to one institution perceived a seizure frequency of ‘one seizure every three 246 
to six months’ to be most reasonable for their pet. Most participants in the current study 247 
perceived only a ‘seizure-free’ state acceptable for their pet (Supplementary file B). Similarly, 248 
freedom from seizures is the treatment goal in people (Lee 2014). It was shown that seizure 249 
frequency is one of the main risk factor for decreased QoL in children with epilepsy (Liu and 250 
Han 2015). A significant correlation between seizure severity and the carer’s perception of their 251 
dog’s QoL could not be established. The statistical analysis did not show whether a history of 252 
‘cluster seizures’ was associated with the dog’s QoL. It appears that the frequency but not their 253 
temporal density was important to carer perceived QoL of their dog. It would appear reasonable 254 
to assume that cluster seizures and status epilepticus impact on the perceived dog’s QoL, given 255 
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that the occurrence of cluster seizures and status epilepticus increased the risk of epilepsy 256 
related euthanasia in previous studies (Saito and others 2001, Monteiro and others 2012, Fredso 257 
and others 2014). This might be related to the fact that the QoL scores are a reflection of the 258 
carer’s perception of their dog’s QoL as a proxy of the dog’s actual QoL.  259 
 260 
The use of two common types of AED (phenobarbital and potassium bromide) had a negative 261 
effect on carer’s perception of their dog’s QoL when considered since the onset of epilepsy, 262 
and there was an effect of the number of AEDs administered, with dogs being treated with third 263 
line drugs experiencing a reduced carer perceived QoL compared to those with 1-2 AEDs. Both, 264 
seizure control and number of medications administered, are significantly associated with QoL 265 
in epileptic children (Williams and others 2003). Drug-resistance is frustrating and challenging 266 
to manage. The probability of seizure control is reduced with successive AED treatment (Lee 267 
2014, Packer and others 2015). Response rates in people with epilepsy for the first, second or 268 
third-line AED as proportion of the population were 47-50%, 10-13% and 2-4% respectively 269 
(Kwan and Brodie 2000, Mohanraj and Brodie 2006). Similarly, in dogs with epilepsy, the 270 
response rate as proportion of the population for first, second and third line AEDs was 37%, 271 
11% and 6% respectively (Packer and others 2015). There was an association between both 272 
seizure frequency and severity and carer-perceived acceptability of these traits, with higher 273 
seizure frequencies and severities perceived to be less acceptable by carers. Drug-resistance 274 
remains a main cause of epilepsy related euthanasia in canine IE (Chang and others 2006, 275 
Fredso and others 2014, Wessmann and others 2014). Although freedom from seizures is one 276 
of the main goals of epilepsy therapy in people (Lee 2014), it is not easily achieved, and with 277 
as few as 14% of treated dogs achieving remission in hospital dog populations (Packer and 278 
others 2014) the management of carer’s expectations by their veterinarians is vital for 279 
understanding the outcomes of therapy. 280 
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 281 
The AED side effects that impact on the dog’s QoL and their acceptability by the carer vary 282 
between the 11 investigated side effects. Only the AED side effects ‘sleeping more’ and the 283 
severity of being ‘wobbly/not coordinated when walking’ significantly predicted carer 284 
perception of their dog’s QoL in a multivariate analysis. ‘Drinking more’ and 285 
‘restlessness/pacing’ had further a significant influence on the dog’s QoL at a univariate level. 286 
However, increased severity of these side effects ‘eating more’, ‘gaining weight’, ‘drinking 287 
more’, ‘urinating more’, ‘sleeping more’, ‘wobbly/not coordinated when walking’ and 288 
‘restlessness/pacing’ were associated with a decreased level of carer acceptability. The variety 289 
of the different side effects may explain discrepancies to previous studies. One study reported 290 
that phenobarbital therapy appeared to have minimal side effects on the overall carer perceived 291 
QoL of the studied dog population and thus did not produce a significant problem for the carers 292 
(Lord and Podell 1999), whereas another study reported that acceptable side effects were one 293 
of the greatest concerns for carers (Chang and others 2006). The presence of side effects is an 294 
outcome measure for successful AED therapy in people (Lee 2014). Newer AEDs commonly 295 
fail to show better efficacy than older AEDs. Thus, the selection of the first-line drug is mostly 296 
lead by the characteristics and frequency of the AED side effects (Lee 2014). With the advent 297 
of newer AEDs in veterinary medicine AED side effects have the potential to drive drug 298 
selection, given the perceived impact of the side effects on the QoL of the dog by the carer. 299 
Despite multiple AEDs being available in human medicine, there remains a need for new AEDs 300 
in canine and human epilepsy with fewer side effects, increased efficacy, drugs with different 301 
mechanism of action with the potential of synergistic combination therapy (Lee 2014).  On the 302 
other hand, third AED currently used in veterinary medicine have largely not been through 303 
clinical trials in dogs to test their efficacy. Therefore one could question the necessity of finding 304 
even newer if the available ones have not been tested. 305 
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 306 
The change in the carer’s perception of their dog’s QoL was significantly associated with the 307 
change in the carer’s QoL after the onset of IE. Carers reporting a decreased QoL in their dogs 308 
were more likely to report that their QoL had also decreased. This response reflects a well-309 
known phenomenon in childhood epilepsy, where the disease not only affects the QoL of the 310 
affected child but also of the carer, usually their parent (Cushner-Weinstein and others 2008, 311 
Lv and others 2009). The factors correlated with parental QoL were seizure control, status 312 
epilepticus, drug side effects, the degree of the child’s anxiety and depression (Lv and others 313 
2009). Lack of control over events, unpredictability of events, sleep deprivation and a feeling 314 
of helplessness are known factors in the development of stress in people (Henn and Vollmayr 315 
2005, Koolhaas and others 2011) and epilepsy influences some, if not all of these factors. 316 
Moreover, up to 50% of mothers are at risk of clinical depression as a consequence caring for 317 
an epileptic child (Ferro and Speechley 2009). Similarly, canine IE can also impact on the 318 
mental health of the carer. A small number of participants commented on suffering to some 319 
degree from depression or panic attacks and feeling isolated as a result of caring for an epileptic 320 
dog (Supplementary file B). Noteworthy is that an improved carer perceived dog’s QoL resulted 321 
also in an improved QoL of the carer demonstrating potentially positive aspects of IE treatment. 322 
This positive finding associated with IE is encouraging and may reflect an enhanced connection 323 
between diseased pet and carer observed for cats with diabetes mellitus and their carers (Niessen 324 
and others 2010).  325 
 326 
This study showed on a large scale, that canine IE has not only an effect on the perceived QoL 327 
of the affected dog but is also significantly associated with the carer’s perceived QoL. Carers 328 
reporting a decreased QoL in their dogs were more likely to report that their QoL had decreased 329 
too. Seizure frequency, severity of AED side effects sleeping more and ataxia and dogs 330 
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receiving third line AEDs were associated with the carer perceived dog’s QoL, with higher 331 
severities predicting lower QoL scores. Thus, optimising seizure control and AED therapy will 332 
not only affect the perceived QoL of the affected dog but also of the carer. The carer’s QoL 333 
affected by caring for an epileptic dog is an important part of IE treatment as the perceived 334 
impact of IE not only on the dogs’ but also on the carers’ QoL is likely to influence a carer’s 335 
choices regarding treatment or euthanasia and requires consideration when treatment options 336 
are discussed.  337 
 338 
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LEGENDS 435 
 436 
Table 1. Impact of antiepileptic drug side effects upon carer perceived dog’s quality of life 437 
score. The factors ‘drinking more’, ‘sleeping more’, ‘wobbly/not coordinated when walking’ 438 
and ‘restlessness/pacing’ were tested in a generalised linear mixed model (glmm) with breed 439 
taken into account as a random effect. The severity of ‘sleeping more’ and the severity of being 440 
‘wobbly/not coordinated when walking’ (p<0.050) significantly predicted carer perceived 441 
dog’s QoL. The less severely the dog is affected by ‘sleeping more’ or being ‘wobbly/not 442 
coordinated when walking’, the higher the carer perceived dog’s QoL score.  443 
 444 
Supplementary file A. Outcome of 7 themes with 36 key questions from a disease-specific IE 445 
online questionnaire as previously published by Wessmann and others (2014).  446 
 447 
Supplementary file B. Outcome of 26 complementary questionnaire items as previously 448 
published by Wessmann and others (2014). 449 
 450 
 451 
452 
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Table 1. Impact of antiepileptic drug side effects upon carer perceived dog’s quality of life 453 
score. The factors ‘drinking more’, ‘sleeping more’, ‘wobbly/not coordinated when walking’ 454 
and ‘restlessness/pacing’ were tested in a generalised linear mixed model (glmm) with breed 455 
taken into account as a random effect. The severity of ‘sleeping more’ and the severity of being 456 
‘wobbly/not coordinated when walking’ (p<0.050) significantly predicted carer perceived 457 
dog’s QoL. The less severely the dog is affected by ‘sleeping more’ or being ‘wobbly/not 458 
coordinated when walking’, the higher the carer perceived dog’s QoL score. 459 
 460 
Risk factor Sub-category Coefficient (95% 
CI) 
SE t P value 
Intercept - 5.7 (4.5-6.9) 0.6 9.2 0.000 
Sleeping more Side effect not present 1.7 (0.4-2.9) 0.6 2.6 0.010 
Very mild 1.3 (-0.1-2.6) 0.7 1.8 0.072 
Mild 1.5 (0.2=2.9) 0.7 2.2 0.030 
Moderate 1.0 (-0.3-2.3) 0.6 1.96 0.114 
Severe 1.4 (-0.1-2.8) 0.8 1.8 0.702 
Very severe Reference 
Wobbly/not 
coordinated 
when walking 
Side effect not present 1.4 (0.4-2.4) 0.5 2.8 0.006 
Very mild 1.1 (-0.0-2.1) 0.5 2.0 0.053 
Mild 0.7 (-0.5-1.8) 0.6 1.1 0.258 
Moderate 0.3 (-0.8-1.4) 0.6 0.6 0.553 
Severe 0.9 (-0.3-2.1) 0.6 1.5 0.138 
Very severe Reference 
CI, confidence interval; SE, standard error  461 
 462 
